These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5860702)

  • 21. [Modalities and classes of modalities of action of physiologically active substances of the receptor type during screening].
    Dmitrieva NV; Kaplun AB; Kosolapov SS; Lobanov VI; Nizhniĭ SV
    Izv Akad Nauk SSSR Biol; 1980; (3):408-14. PubMed ID: 7391338
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study of the influence of beta-adrenergic stimulants and adrenergic blocking drugs on renal function in normal humans].
    Bufano G; Piacentini L
    Minerva Med; 1969 Apr; 60(27):1229-32. PubMed ID: 5781346
    [No Abstract]   [Full Text] [Related]  

  • 23. Modifying action of pre-treatment by adrenaline depleting agents on response of rat auricles to sympathomimetic amines.
    Tiwari NM
    J Exp Med Sci; 1966 Mar; 9(4):67-71. PubMed ID: 5997478
    [No Abstract]   [Full Text] [Related]  

  • 24. The peripheral vascular effects of beta adrenergic blocking agents in man.
    Mahon WA
    Angiologica; 1966; 3(5):304-17. PubMed ID: 5957697
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of catecholamines and their antagonists on the responses of the dental areas of the cerebral cortex evoked by dental pulp stimulation in the rabbit].
    Degtiarev VP; Gromov AN
    Farmakol Toksikol; 1981; 44(4):404-6. PubMed ID: 7306305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenergic mediators.
    Nickerson M
    Invest Ophthalmol; 1965 Dec; 4(6):1085-94. PubMed ID: 5321925
    [No Abstract]   [Full Text] [Related]  

  • 27. The pharmacology of a series of new sympatholytic agents.
    NICKERSON M; GOODMAN LS
    Rocky Mt Med J; 1947 Apr; 44(4):290. PubMed ID: 20290044
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sympathomimetic amines].
    ZYKA J
    Cas Cesk Lek; 1950 Oct; 63(19):228-32. PubMed ID: 14772764
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacology of a series of new sympatholytic agents (tertiary amines).
    NICKERSON M; GOODMAN LS
    Proc Am Fed Clin Res; 1945; 2():109. PubMed ID: 20275649
    [No Abstract]   [Full Text] [Related]  

  • 30. [Centrally acting sympathetic inhibitors].
    Noshiro T; Miura Y
    Nihon Rinsho; 1992 Apr; 50 Suppl():686-93. PubMed ID: 1635257
    [No Abstract]   [Full Text] [Related]  

  • 31. Adrenergic receptors and the physician.
    Somani P
    Wis Med J; 1968 Jun; 67(6):296-300. PubMed ID: 5655731
    [No Abstract]   [Full Text] [Related]  

  • 32. Dichloro-isuprel inhibition of sympathomimetic hyperglycaemia.
    CLAASSEN V; NOACH EL
    Arch Int Pharmacodyn Ther; 1960 Jul; 126():332-40. PubMed ID: 13810396
    [No Abstract]   [Full Text] [Related]  

  • 33. [Alpha and beta adrenergic receptors. The interesting history of a curious concept].
    Kalsbeek F
    Ned Tijdschr Geneeskd; 1969 Mar; 113(9):383-90. PubMed ID: 4889686
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of Th 1165a activity in different effector areas].
    Brugger AJ; Sopena M; Salvá JA
    Rev Esp Fisiol; 1969 Mar; 25(1):29-33. PubMed ID: 5816531
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacodynamic agents acting on the adrenergic receptors: their applications in cardiology].
    Warembourg H; Bertrand M; Delomez M
    Lille Med; 1967 Jan; 12(1):77-81. PubMed ID: 5597458
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences in central anticholinergic actions of phenothiazine derivatives.
    WHITE RP; WESTERBEKE EJ
    Exp Neurol; 1961 Oct; 4():317-29. PubMed ID: 14006567
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution and role of the adrenergic receptors: therapeutic value].
    Moline J; Harichaux P
    Presse Med (1893); 1967 Apr; 75(18):901-4. PubMed ID: 6023843
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of adrenergic alpha- and beta-receptor blocking drugs on the myocardial lesions induced by sympathomimetic amines.
    Méhes G; Papp G; Rajkovits K
    Acta Physiol Acad Sci Hung; 1967; 32(1):175-84. PubMed ID: 6080429
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacology of the pulmonary circulation].
    Zocche GP
    Minerva Anestesiol; 1967 Jan; 33(1):74-7. PubMed ID: 5596016
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adrenergic transport systems].
    Oelszner W
    Pharm Prax; 1968; 4():76-80. PubMed ID: 5732260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.